Development of hypertrophic and keloid scars after removal of tunneled central venous catheters in childhood cancer survivors MedDRA version: 12.0 Level: LLT Classification code 10020879 Term: Hypertrophic scar MedDRA version: 12.0 Level: LLT Classification code 10023330 Term: Keloid scar
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children aged 0-17 years treated for cancer at the Department of Pediatrics at Aarhus University Hospital Skejby, who have had a tunneled central venous catheter and who have the catheter removed due to end of treatment in the study period. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: known allergy towards fusidic acid or plaster
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To examine whether treament with corticosteroid cream after removal of tunneled central venous catheter can reduce the development of hypertrophic and keloid scars in childhood cancer survivors;Secondary Objective: ;Primary end point(s): Scar measurement by Vancouver Scar Scale 12 month after removal of the catheter | — |
Countries
Denmark